Google

News for Esophageal Cancer 

Latest Esophageal Cancer News

Esophageal cancer is a malignancy that develops in tissues of the hollow, muscular canal (esophagus) along which food and liquid travel from the throat to the stomach. About 13,000 new cases of esophageal cancer are diagnosed in the United States each year.
This page is dedicated to latest news for patients, caregivers, physicians, and researchers whose interest is the esophageal cancer. We hope you find this news site helpful and informative.

RSS Feed
Subscribe to Esophageal Cancer RSS Newsfeed.
email Report
 
Esophageal Cancer Resources    Link to us
 

Esophageal Cancer
Esophageal cancer Definition Esophageal cancer is a malignancy that develops in tissues of the hollow, muscular canal (esophagus) along which food and liquid travel from the throat to the stomach. Description Esophageal cancer usually originates in the inner layers of the lining of the esophagus

Access to care and stage at diagnosis for patients with lung cancer and esophageal cancer: analysis of the Savannah River Region Information System cancer registry data.
ABSTRACT Background. Disparities have been observed in both the incidences of lung and esophageal cancers and the survival of those patients. Our goals were to determine if race was associated with stage of cancer at diagnosis, and to identify predictors of advanced-stage lung and esophageal

Esophageal cancer: a review and update.
Although significant advancements have been made in the treatment of esophageal cancer, this aggressive malignancy commonly presents as locally advanced disease with a poor prognosis. Despite improvements in the detection of premalignant pathology, newer preventative strategies, and the development

Multimodality treatment for esophageal cancer: The role of surgery and neoadjuvant therapy
Treatment of esophageal cancer has traditionally included surgery as the initial modality. Neoadjuvant chemoradiation therapy has been introduced with the goal of downstaging tumors before surgical resection; however, its role in esophageal cancer remains controversial. We report 116 patients who

Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET
To evaluate glucose metabolism in esophageal cancer, 48 patients were studied using PET with ^sup 18^F-2-fluoro-2-deoxy-D-glucose (FDG). Methods: After transmission scans were obtained, '8F-FDG (148 MBq) was administered intravenously. In 11 patients, a dynamic study was performed to evaluate

Risk factors of esophageal cancer in Turkmen Sahra of Iran
ABSTRACT Present study was carried out in three years' duration (2002-2004) to investigate the risk factors of esophageal cancer in Iranian Turkmens (Northeast of Iran; where the esophageal cancer is the most common world wide). Concerning registered cases of esophageal cancer in the region, 139

Comparison of ^sup 18^F-FLT PET and ^sup 18^F-FDG PET in Esophageal Cancer
18F-FDG PET has gained acceptance for staging of esophageal cancer. However, FDG is not tumor specific and false-positive results may occur by accumulation of FDG in benign tissue. The tracer ^sup 18^F-fluoro-3'-deoxy-3'-L-fluorothymidine (^sup 18^F-FLT) might not have these drawbacks. The aim of

Increased risk of esophageal cancer among workers exposed to combustion products.
There are striking geographical variations in the incidence of esophageal cancer, which imply that environmental factors are of prime etiologic importance.[1] Alcohol and tobacco habits have been identified as important risk factors for the disease. In addition, increased risks of esophageal cancer

Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy
The accuracy of endoscopic ultrasound (EUS) for initial staging of esophageal cancer is widely accepted. There is, however, considerable variability in the reported accuracy of EUS for restaging of esophageal neoplasms after neoadjuvant therapy. From June 1995 through December 1999, we

Esophageal Cancer: An Overview.
Easophageal cancer is the second most common solid intrathoracic malignancy. It accounts for 6% of all malignant tumors of the gastrointestinal tract and represents 1% of all cancers in the United States (American Joint Committee on Cancer, 1998; Landis, Murray, Bolden, & Wingo, 1999). In 1999,

 
Google
Breast Cancer News Colon Cancer News Lung Cancer News Prostate Cancer News Skin Cancer News Liver Cancer News Cancer News RSS Feeds The Basics explained Cancer News RSS Feeds